Pancreatic Cancer Research

ResearcherUniversity Health NetworkActive in the last 2 years

Raymond Jang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1504-5175; OpenAlex author ID A5018076810, A5065784545, A5110560640. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 4 papers

Papers 7

  1. Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial. Co-author DOI 10.1038/s41467-025-60808-z↗
  2. The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer. Co-author DOI 10.1038/s41698-025-00888-8↗
  3. PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Panc… Co-author DOI 10.1200/jco-25-00436↗
  4. Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metast… Co-author DOI 10.1200/jco-25-02195↗
  5. Impact of an Inter-Professional Clinic on Pancreatic Cancer Outcomes: A Retrospective Cohort Study. Co-author DOI 10.3390/curroncol31050194↗
  6. Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2020-320730↗
  7. Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. Co-author DOI 10.1093/jnci/dju424↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jennifer Jane Knox · 6 shared papers, 2021–2025 · strength 0.91
  2. Steve Gallinger · 6 shared papers, 2021–2025 · strength 0.91
  3. Sandra Elisabeth Fischer · 5 shared papers, 2021–2025 · strength 0.75
  4. Robert C. Grant · 5 shared papers, 2021–2025 · strength 0.75
  5. Grainne Mary O'Kane · 5 shared papers, 2021–2025 · strength 0.75
  6. Faiyaz Notta · 5 shared papers, 2021–2025 · strength 0.75
  7. Erica S. Tsang · 4 shared papers, 2025 · strength 0.65
  8. Daniel John Renouf · 4 shared papers, 2021–2025 · strength 0.59
  9. Malcolm J. Moore · 3 shared papers, 2024–2025 · strength 0.49
  10. Kyaw Lwin Aung · 3 shared papers, 2024–2025 · strength 0.49
  11. Spring Holter · 3 shared papers, 2021–2025 · strength 0.42
  12. George Zogopoulos · 3 shared papers, 2021–2025 · strength 0.42
  13. Harshabad Singh · 2 shared papers, 2025 · strength 0.33
  14. Craig Devoe · 2 shared papers, 2025 · strength 0.33
  15. Kai Duan · 2 shared papers, 2025 · strength 0.33
  16. Eileen Mary O'Reilly · 2 shared papers, 2025 · strength 0.33
  17. Fieke E. M. Froeling · 2 shared papers, 2025 · strength 0.33
  18. Michelle Chan‐Seng‐Yue · 2 shared papers, 2025 · strength 0.33
  19. Daniel A. King · 2 shared papers, 2025 · strength 0.33
  20. Andrew J. Aguirre · 2 shared papers, 2025 · strength 0.33
  21. Elizabeth M. Jaffee · 2 shared papers, 2025 · strength 0.33
  22. Brian Matthew Wolpin · 2 shared papers, 2025 · strength 0.33
  23. Kimberly J. Perez · 2 shared papers, 2025 · strength 0.33
  24. Michael Jon Pishvaian · 2 shared papers, 2025 · strength 0.33
  25. David Arthur Tuveson · 2 shared papers, 2025 · strength 0.33

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.